参考文献/References:
[1]DIAZ-SAN-SEGUNDO F, MEDINA G N, STENFELDT C, et al. Foot-and-mouth disease vaccines[J]. Veterinary Microbiology,2017,206:102-112.
[2]李乐,苗海生,信爱国,等. ELISA用于口蹄疫病毒146S抗原快速定量的研究[J]. 中国预防兽医学报,2008,30(4):314-317.
[3]FENG X, MA J W, SUN S Q, et al. Quantitative detection of the foot-and-mouth disease virus serotype o 146s antigen for vaccine production using a double-antibody sandwich ELISA and nonlinear standard curves[J]. PLoS One,2016,11(3):e0149569.
[4]刘玉梅,刘飞,孙艳琪,等. 蔗糖密度梯度法定量口蹄疫完整病毒粒子(146S)的特异性研究[J]. 中国兽药杂志,2012,46(11):6-8.
[5]宋艳民,杨延丽,苏志国,等. 高效体积排阻色谱法定量检测口蹄疫疫苗中146S的疫苗预处理方法[J]. 生物工程学报,2019,35(8):1441-1452.
[6]WAMBURA P N, MZULA A. A novel rapid direct haemagglutination-inhibition assay for measurements of humoral immune response against non-haemagglutinating Fowlpox virus strains in vaccinated chickens[J]. Heliyon,2017,3(10):e00428.
[7]KIRBY F D, MARTIN H T, OSTLER D C. An indirect haemagglutination test for the detection and assay of antibody to infectious bovine rhinotracheitis virus[J]. Veterinary Record,1974,94(16):361-362.
[8]HITZLER W E, RUNKEL S, et al. Prevalence of human parvovirus B19 in blood donors as determined by a haemagglutination assay and verified by the polymerase chain reaction[J]. Vox Sanguinis,2002,82(1):18-23.
[9]HABIB I, SMOLAREK D, HATTAB C, et al. V(H)H (nanobody) directed against human glycophorin A:a tool for autologous red cell agglutination assays[J]. Analytical Biochemistry,2013,438(1):82-89.
[10]CHEN Y P, QIAO Y Y, ZHAO X H, et al. Rapid detection of hepatitis b virus surface antigen by an agglutination assay mediated by a bispecific diabody against both human erythrocytes and hepatitis B virus surface antigen[J]. Clinical & Vaccine Immunology,2007,14(6):720-725.
[11]CHENG H, YANG L, CAI Z, et al. Development of haemagglutination assay for titration of porcine circovirus type 2[J]. Analytical Biochemistry,2020,598:113706.
[12]CHENG H, CHEN J, CAI Z, et al. Development of GEM-PA-nanotrap for purification of foot-and-mouth disease virus[J]. Vaccine,2019,37(24):3205-3213.
[13]KIM A-Y, PARK S Y, PARK S H, et al. Validation of pretreatment methods for the in-process quantification of foot-and-mouth disease vaccine antigens[J]. Vaccines,2021,9(11):1361.
[14]SONG Y, YANG Y, LIN X, et al. On-line separation and quantification of virus antigens of different serotypes in multivalent vaccines by capillary zone electrophoresis:a case study for quality control of foot-and-mouth disease virus vaccines[J]. Journal of Chromatography A,2021,1637:461834.
[15]KIM M H,YUN S J,KIM Y H,et al. Evaluation of quality control methods for foot-and-mouth disease vaccines by high-performance liquid chromatography[J]. Pathogens,2020,9(3):194.
[16]KIM A Y, PARK S Y, PARK S H, et al. Comparison of high-performance liquid chromatography with sucrose density gradient ultracentrifugation for the quantification of foot-and-mouth disease vaccine antigens[J]. Vaccines(Basel),2022,10(5):667.
[17]HARMSEN M M, FIJTEN H P, WESTRA D F, et al. Effect of thiomersal on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles as assessed by novel ELISAs specific for either 146S or 12S particles[J]. Vaccine,2011,29(15):2682-2690.
[18]卢清侠,李伟,金前跃,等. 鹅星状病毒刺突蛋白单克隆抗体的制备与鉴定[J]. 江苏农业科学,2022,50(22):159-165.
[19]刘建欣,刘蕾,郭珊珊,等. 副溶血性弧菌外膜蛋白BamA重组表达及其免疫原性分析[J]. 江苏农业科学,2022,50(15):43-50.
[20]卢春霞,刘长彬,万鹏程,等. 绵羊ovPAG7间接竞争酶联适配体检测方法的建立与应用[J]. 江苏农业学报,2022,38(3):730-738.
[21]GOPINATH S C B, KUMAR P K R. Aptamers that bind to the hemagglutinin of the recent pandemic influenza virus H1N1 and efficiently inhibit agglutination[J]. Acta Biomaterialia,2013,9(11):8932-8941.
[22]KILLIAN M L. Hemagglutination assay for influenza virus[J]. Methods in Molecular Biology,2020,2123:3-10.
[23]KRISHNAMURTHY A, JIMENO A. Bispecific antibodies for cancer therapy:a review[J]. Clinical Pharmacology & Therapeutics,2018,185:122-134.
[24]LIU M, LI L, JIN D, et al. Nanobody-A versatile tool for cancer diagnosis and therapeutics[J]. Wiley Interdisciplinary Reviews:Nanomedicine and Nanobiotechnology,2021,13(4):e1697.